Skip to main content
. 2013 Apr 24;6(1):130–134. doi: 10.3892/ol.2013.1317

Table II.

EGFR immunoreactivity in human gliomas

Grade Immunonegative cases, n (%) Immunopositive cases, n (%)
+ ++ +++ Total
I 7 (77.8) 2 (22.2) 0 (0.0) 0 (0.0) 2 (22.2)
II 31 (55.4) 15 (26.8) 6 (10.7) 4 (7.1) 25 (44.6)
III 15 (28.8) 8 (15.4) 17 (32.7) 12 (23.1) 37 (71.2)
IV 4 (11.4) 3 (8.6) 10 (28.6) 18 (51.4) 31 (88.6)

P=0.021, grade I and II vs. grade III and IV (χ2 test). EGFR, epidermal growth factor receptor.